{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:11Z","timestamp":1791849491167,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1053\/j.ajkd.2011.03.031","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T11:00:20Z","timestamp":1309518020000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Red Blood Cell Survival in Long-term Dialysis Patients"],"prefix":"10.1053","volume":"58","clinical-trial-number":[{"clinical-trial-number":"actrn12610000145000","registry":"10.18810\/anzctr"}],"author":[{"given":"Frederiek E.","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Schollum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn V.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence C.A.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Duffull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2011.03.031_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.V132504","article-title":"Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey","volume":"13","author":"Hsu","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.03.031_bib3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.ajkd.2011.03.031_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000416004","article-title":"Modern aspects of the pathophysiology of renal anemia","volume":"66","author":"Eschbach","year":"1988","journal-title":"Contrib Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib5","first-page":"83","article-title":"The anemia associated with renal disease","volume":"52","author":"Kaye","year":"1958","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.ajkd.2011.03.031_bib6","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1046\/j.1523-1755.2001.59780067.x","article-title":"Role of uremic toxins in exacerbating anemia in renal failure","volume":"78","author":"Macdougall","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2011.03.031_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(58)90357-7","article-title":"Characterization of the anemia associated with chronic renal insufficiency","volume":"24","author":"Loge","year":"1958","journal-title":"Am J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2011.03.031_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM196703232761202","article-title":"Erythropoiesis in patients with renal failure undergoing chronic dialysis","volume":"276","author":"Eschbach","year":"1967","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.03.031_bib9","first-page":"511","article-title":"Isotope investigations of red cell production and destruction in chronic renal disease","volume":"15","author":"Joske","year":"1956","journal-title":"Clin Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2011.03.031_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0272-6386(04)00951-5","article-title":"Red blood cell survival in chronic renal failure","volume":"44","author":"Ly","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2011.03.031_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.2830460207","article-title":"Use of alveolar carbon monoxide measurements to assess red blood cell survival in hemodialysis patients","volume":"46","author":"Medina","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1053\/j.ajkd.2011.03.031_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.2.5546.213","article-title":"Haemolysis in chronic renal failure","volume":"2","author":"Shaw","year":"1967","journal-title":"Br Med J"},{"key":"10.1053\/j.ajkd.2011.03.031_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archinte.1958.00260140158024","article-title":"The anemia of renal failure","volume":"101","author":"Desforges","year":"1958","journal-title":"AMA Arch Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000044878","article-title":"Red blood cell osmotic fragility in chronically hemodialyzed patients","volume":"78","author":"Wu","year":"1998","journal-title":"Nephron"},{"issue":"9","key":"10.1053\/j.ajkd.2011.03.031_bib15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1681\/ASN.V1091982","article-title":"Increased erythrocyte phosphatidylserine exposure in chronic renal failure","volume":"10","author":"Bonomini","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2011.03.031_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/ndt\/12.11.2375","article-title":"The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability","volume":"12","author":"Linde","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2011.03.031_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V21.1.63.63","article-title":"The red cell chromium elution rate in patients with some hematologic diseases","volume":"21","author":"Cline","year":"1963","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.ajkd.2011.03.031_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI102855","article-title":"The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination of red cell survival in vivo","volume":"29","author":"Ebaugh","year":"1953","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2011.03.031_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood-2002-02-0500","article-title":"Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation","volume":"101","author":"Willekens","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ajkd.2011.03.031_bib21","first-page":"283","article-title":"RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy","volume":"38","author":"Schwartz","year":"1992","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.03.031_bib22","first-page":"M691","article-title":"One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis","volume":"36","author":"Schwartz","year":"1990","journal-title":"ASAIO Trans"},{"issue":"4","key":"10.1053\/j.ajkd.2011.03.031_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.1980.tb07189.x","article-title":"Recommended method for radioisotope red-cell survival studies","volume":"45","author":"Berlin","year":"1980","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0375-9474(97)00482-X","article-title":"The NUBASE evaluation of nuclear and decay properties","volume":"624","author":"Audi","year":"1997","journal-title":"Nucl Phys A"},{"key":"10.1053\/j.ajkd.2011.03.031_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0609.1997.tb01662.x","article-title":"Quantification of loss of haemoglobin components from the circulating red blood cell in vivo","volume":"58","author":"Willekens","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.ajkd.2011.03.031_bib26","first-page":"5","article-title":"Nutritional anaemias","volume":"405","year":"1968","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9343(55)90335-1","article-title":"The anemia of uremia: hemolytic state measured by the radiochromium method [abstract]","volume":"19","author":"Sutherland","year":"1955","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/clpt.1992.10","article-title":"A pharmacodynamic model of erythropoietin therapy for uremic anemia","volume":"51","author":"Uehlinger","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000182727","article-title":"Haemolysis in chronic renal failure","volume":"32","author":"Hocken","year":"1982","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2011.03.031_bib30","series-title":"Harrison's Principles of Internal Medicine","author":"Fauci","year":"2008"},{"issue":"3","key":"10.1053\/j.ajkd.2011.03.031_bib31","first-page":"283","article-title":"The rate and control of baseline red cell production in hematologically stable patients with uremia","volume":"126","author":"Erslev","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.ajkd.2011.03.031_bib32","first-page":"469","article-title":"Effect of hemodialysis on erythrokinetics in anemia of uremia","volume":"63","author":"Kurtides","year":"1964","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.ajkd.2011.03.031_bib33","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.2000.07606.x","article-title":"The removal of uremic toxins","volume":"76","author":"Dhondt","year":"2000","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2011.03.031_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(82)90577-0","article-title":"Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin","volume":"72","author":"Zappacosta","year":"1982","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.03.031_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/039139880803100610","article-title":"Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study","volume":"31","author":"Cruz","year":"2008","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1053\/j.ajkd.2011.03.031_bib36","first-page":"327","article-title":"Red blood cell destruction in single-needle dialysis","volume":"31","author":"Dhaene","year":"1989","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.03.031_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.1984.36","article-title":"Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency","volume":"25","author":"McGonigle","year":"1984","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2011.03.031_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-111-12-992","article-title":"Recombinant human erythropoietin in anemic patients with end-stage renal disease","volume":"111","author":"Eschbach","year":"1989","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1053\/j.ajkd.2011.03.031_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V781178","article-title":"Is erythropoietin a survival factor for red blood cells?","volume":"7","author":"Polenakovic","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"262","key":"10.1053\/j.ajkd.2011.03.031_bib40","first-page":"113","article-title":"Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO)","volume":"70","author":"Cotes","year":"1989","journal-title":"Q J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611008493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611008493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:58:12Z","timestamp":1759456692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638611008493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0272638611008493"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.03.031","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Blood Cell Survival in Long-term Dialysis Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}